Discovery and Characterization of Ephrin B2 and EphB4 Dysregulation and Novel Mutations in Cerebral Cavernous Malformations: In Vitro and Patient-Derived Evidence of Ephrin-Mediated Endothelial Cell Pathophysiology
Julie Sesen(Boston Children's Hospital), Katie Fehnel(Boston Children's Hospital)
Cited by 4
Related Papers
Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response
|PLoS ONE|2015|204
Mutation of key signaling regulators of cerebrovascular development in vein of Galen malformations
|Nature Communications|2023|26
Dysregulation of the EphrinB2−EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients
|Experimental & Molecular Medicine|2020|25
Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors
|Oncotarget|2018|21
Genetic dysregulation of an endothelial Ras signaling network in vein of Galen malformations
|bioRxiv (Cold Spring Harbor Laboratory)|2023|3